HNF4A and liver cancer: The reason is, perhaps, that SMC treatment only led to slight elevation of HNF4α expression in normal primary hepatocytes, whose expression level is already fairly high, unlike in liver cancer cells, where SMC's induction could enhance the HNF4α expression much more significantly.